StockData
GH Research PLC logo

GH Research PLC (GHRS) stock

GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$18.75−0.35 (-1.83%)

Close on Nov 16, 2026Market cap $1.16BP/E –Yield –

GH Research EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

GH Research's EPS for the twelve months ending Jun 30, 2026 was -$1.00. For fiscal 2025 it was -$0.79. The highest annual figure on record is -$0.01 in fiscal 2019.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.79–
FY2024Dec 31, 2024-$0.75–
FY2023Dec 31, 2023-$0.68–
FY2022Dec 31, 2022-$0.43–
FY2021Dec 31, 2021-$0.21–
FY2020Dec 31, 2020-$0.02–
FY2019Dec 31, 2019-$0.01–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.23–
Q1 FY2026Mar 31, 2026-$0.31–
Q4 FY2025Dec 31, 2025-$0.23–
Q3 FY2025Sep 30, 2025-$0.23–
Q2 FY2025Jun 30, 2025-$0.15–
Q1 FY2025Mar 31, 2025-$0.19–
Q4 FY2024Dec 31, 2024-$0.17–
Q3 FY2024Sep 30, 2024-$0.23–
Q2 FY2024Jun 30, 2024-$0.20–
Q1 FY2024Mar 31, 2024-$0.15–
Q4 FY2023Dec 31, 2023-$0.22–
Q3 FY2023Sep 30, 2023-$0.11–
Q2 FY2023Jun 30, 2023-$0.15-1600.0%
Q1 FY2023Mar 31, 2023-$0.21–
Q4 FY2022Dec 31, 2022-$0.32–
Q3 FY2022Sep 30, 2022-$0.01–
Q2 FY2022Jun 30, 2022$0.01–

More GH Research figures

See a number that looks wrong?